Skip to content
Screener

Savara SVRA Income Tax

Income Tax at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
-$24.6M-376%
XER
Xeris Biopharma Holdings, Inc.XERS
$0—
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$4.04M+83.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$12.39M+527%
PVL
Palvella TherapeuticsPVLA
$0—
TRV
Trevi Therapeutics, Inc.TRVI
-$20K-81.8%

Other financials

Income statement

See full
Revenue-—
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+151%
Enterprise value$1.18B+142%

Profitability

See full
Operating margin-19,183.3%—
Net margin-19,305.1%—
FCF margin-15,518.7%—

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Savara’s 10-K, filed March 12, 2020. Open the filing →

Filed
Mar 12, 2020, 4:11 PM EDT
Fiscal year
FY2019
Accession
0001564590-20-010465

FAQ

What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.